CCL2 and cancer: Another study focused on the GC hepatic premetastatic niche revealed that the ephrin A1-initialized YAP1-CCL2-Wnt/β-catenin axis bridged the malignant communications between cancer cells and hepatic stellate cells during GC hepatic metastasis [51].